The dynamics of drug resistance within hospital populations of Gram-negative bacteria
The dynamics of drug resistance within hospital populations of Gram-negative bacteria
批准号:
MR/P014658/1
负责人:
Gwenan Knight
金额:
$41.71万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
When bacteria become resistant to antibiotics the infections they cause are harder to treat. In the UK, and globally, we are seeing an increase in the number of infections being caused by antibiotic resistant bacteria. This could lead us back into the pre-antibiotic era before the early 1900s when infections of simple cuts may become life threatening and cancer treatments which suppress the immune system, and rely on antibiotics to prevent infections, will be unusable. Antibiotic resistance arises through the use and misuse of antibiotics and so, even if we develop new antibiotics, it is likely that we will always be faced with the problem of resistant strains. We need to consider how best to preserve our existing antibiotics without compromising patient care. One of the ways to do this is to look at why some places have less resistance than others and to try to work out what they are doing right. For example, some hospitals have fewer infections with resistant bacteria than others. In this project I will explore what the reasons for these differences might be and translate these findings into ways to better prevent resistance from spreading. To do this I will build mathematical models of antibiotic resistance spread. Mathematical models are frameworks in which different subpopulations are separated out and the rates at which these sub-groups increase or decrease are calculated. For example, a model would split a hospital population into those with and without infections with resistant or susceptible bacteria. It would then consider at what rate and by what mechanism people become infected, and then explore what the difference is between those with and without resistance. By writing this framework down mathematically, we get a better understanding of the processes underlying the spread of resistance and can identify the key targets - for example overuse of a certain type of antibiotic - that need to be tackled. From this understanding of the resistance spread, the model can be used to predict what will happen in the future without interventions and then compare this to what would happen if certain interventions were introduced. I will build mathematical models that capture what is happening in different hospitals and determine why some have lower rates of resistance than others. In particular, I will look at the development of resistance within a group of bacteria called the Gram-negatives. These bacteria are often found living in the gut, but they can travel to other parts of the body and, in the UK, are the most common cause of serious hospital-associated infections such as bacteraemia (infection of the blood). Increasingly we are seeing strains of these bacteria becoming resistant to common, powerful antibiotics and so they are a key contributor to antibiotic resistance. Groups of bacteria can have very different characteristics and can grow extremely rapidly. Their genetic make-up is very flexible which means that new genetic changes can occur or new pieces of genetic material can jump between bacteria creating and spreading resistance. In a bacterial population there will then be many different strains that may have many different resistances. This diversity has rarely been considered in mathematical models before, and so we may be missing a key part of resistance evolution. In this project I will develop mathematical models to incorporate this diversity and to determine how much of an impact it is having on resistance spread.Mathematical models must be grounded in data in order to be relevant to clinicians and public health. In this project I will use the newly collected hospital level data on antibiotic usage and resistance to both gain parameters for my models and to determine what patterns the models should capture. My results will then be immediately useful for clinicians and the NHS, and will directly influence the interventions used to control the appearance and spread of antibiotic resistance.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks.
在Covid-19爆发中存在过度传播的情况下,向后接触的含义。
DOI:
10.12688/wellcomeopenres.16344.3
发表时间:
2020
期刊:
Wellcome open research
影响因子:
--
作者:
[Endo A, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, Leclerc QJ, Knight GM, Medley GF, Atkins KE, Funk S, Kucharski AJ]
通讯作者:
Kucharski AJ
DOI:
10.7554/elife.58699
发表时间:
2020-08-24
期刊:
eLife
影响因子:
7.7
作者:
[Emery JC, Russell TW, Liu Y, Hellewell J, Pearson CA, CMMID COVID-19 Working Group, Knight GM, Eggo RM, Kucharski AJ, Funk S, Flasche S, Houben RM]
通讯作者:
Houben RM
DOI:
10.1128/spectrum.00615-22
发表时间:
2022-10-26
期刊:
MICROBIOLOGY SPECTRUM
影响因子:
3.7
作者:
[Baede, Valerie O., Tavakol, Mehri, Vos, Margreet C., Knight, Gwenan M., van Wamel, Willem J. B.]
通讯作者:
van Wamel, Willem J. B.
Selecting Efficient Farm-level Antimicrobial Stewardship Interventions from a One Health perspective
-
批准号:MR/W031310/1
-
项目类别:Research Grant
-
资助金额:$58.66万
-
财政年份:2022
-
负责人:Gwenan Knight
-
依托单位:
Colliding crises: antimicrobial resistance and ageing
-
批准号:MR/W026643/1
-
项目类别:Fellowship
-
资助金额:$144.58万
-
财政年份:2022
-
负责人:Gwenan Knight
-
依托单位:
Nosocomial transmission of SARS-CoV-2
-
批准号:MR/V028456/1
-
项目类别:Research Grant
-
资助金额:$16.32万
-
财政年份:2020
-
负责人:Gwenan Knight
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
泛素结合酶UBE2S调控GPX4/SLC7A11影响肝癌细胞铁死亡的机制研究
-
批准号:32060159
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:莫之婧
-
依托单位:
m6A识别蛋白YTHDF2促白血病细胞生长的研究
-
批准号:32070793
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:赵昀
-
依托单位:
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
-
批准号:32000555
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐亮
-
依托单位:
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
-
批准号:31900528
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:王真
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位: